Gunnar Olof Olsson

Dr. Gunnar Olof Olsson is an Independent Director at Cereno Scientific AB, a Chairman at Betagenon Sweden AB, a Chairman at Betagenon Bio AB and a Principal at Olsson Solutions Kommanditbolag.
He is on the Board of Directors at Cereno Scientific AB, IRLAB Therapeutics AB, Amplifier TX AB, BioCrine AB, Gesynta Pharma AB, Olsson Solutions AB, Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt and University of Lund.
Dr. Olsson was previously employed as a Manager-Global Cardiovascular by AstraZeneca AB and a Chairman by Athera Biotechnologies AB. He also served on the board at The European Society of Cardiology.
He received his undergraduate degree from the International Institute for Management Development and a doctorate degree from Karolinska Institutet.